Adherence to Therapies in Patients with Type 2 Diabetes

被引:0
作者
Luis-Emilio García-Pérez
María Álvarez
Tatiana Dilla
Vicente Gil-Guillén
Domingo Orozco-Beltrán
机构
[1] Lilly,Global Medical Affairs, Medical Department
[2] S.A.,Medical Department
[3] Lilly,Department of Clinical Medicine, Cathedra of Family Medicine
[4] S.A.,undefined
[5] University Miguel Hernández,undefined
来源
Diabetes Therapy | 2013年 / 4卷
关键词
Adherence; Dosing complexity; Glycemic control; Primary care; Type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
Adherence to therapy is defined as the extent to which a person’s behavior in taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a healthcare provider. Patients presenting with type 2 diabetes mellitus are initially encouraged to maintain a healthy diet and exercise regimen, followed by early medication that generally includes one or more oral hypoglycemic agents and later may include an injectable treatment. To prevent the complications associated with type 2 diabetes, therapy frequently also includes medications for control of blood pressure, dyslipidemia and other disorders, since patients often have more than three or four chronic conditions. Despite the benefits of therapy, studies have indicated that recommended glycemic goals are achieved by less than 50% of patients, which may be associated with decreased adherence to therapies. As a result, hyperglycemia and long-term complications increase morbidity and premature mortality, and lead to increased costs to health services. Reasons for nonadherence are multifactorial and difficult to identify. They include age, information, perception and duration of disease, complexity of dosing regimen, polytherapy, psychological factors, safety, tolerability and cost. Various measures to increase patient satisfaction and increase adherence in type 2 diabetes have been investigated. These include reducing the complexity of therapy by fixed-dose combination pills and less frequent dosing regimens, using medications that are associated with fewer adverse events (hypoglycemia or weight gain), educational initiatives with improved patient–healthcare provider communication, reminder systems and social support to help reduce costs. In the current narrative review, factors that influence adherence to different therapies for type 2 diabetes are discussed, along with outcomes of poor adherence, the economic impact of nonadherence, and strategies aimed at improving adherence.
引用
收藏
页码:175 / 194
页数:19
相关论文
共 335 条
[1]  
Cheung BM(2009)Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006 Am J Med 122 443-453
[2]  
Ong KL(2009)Adherence to healthy lifestyle habits in US adults, 1988–2006 Am J Med 122 528-534
[3]  
Cherny SS(2006)Type 2 diabetes in children and adolescents—the next epidemic? Curr Med Res Opin 22 297-306
[4]  
Sham PC(2013)Standards of medical care in diabetes: 2013 Diabetes Care 36 S11-S66
[5]  
Tso AW(2004)Trends in complexity of diabetes care in the United States from 1991 to 2000 Arch Intern Med 164 1134-1139
[6]  
Lam KS(2005)Adherence to medication N Engl J Med 353 487-497
[7]  
King DE(2008)Medication compliance and persistence: terminology and definitions Value Health 11 44-47
[8]  
Mainous AG(2005)Impact of compliance with oral antihyperglycemic agents on health outcomes in type 2 diabetes mellitus: a focus on frequency of administration Treat Endocrinol 4 167-175
[9]  
Carnemolla M(2009)Medication adherence: its importance in cardiovascular outcomes Circulation 119 3028-3035
[10]  
Everett CJ(2004)The impact of compliance with osteoporosis therapy on fracture rates in actual practice Osteoporos Int 15 1003-1008